EEKEM Group launches a simplified public purchase offer for UTI Group

EEKEM Group has initiated a simplified public purchase offer (OPAS) targeting the shares of UTI Group. The Financial Markets Authority (AMF) has given its approval to the transaction, with the conformity decision dated December 16, 2024. Visa No. 24-520 has been affixed to the information note relating to this offer.

If, following the offer, less than 10% of UTI Group's capital remains in the hands of minority shareholders, EEKEM Group plans to request a mandatory squeeze-out from the AMF. The shares not tendered to the offer would then be transferred to EEKEM Group, with compensation equal to the offer price for each share, net of fees.

Documents detailing the legal, financial and accounting characteristics of EEKEM Group are available on the AMF website and from the company in Lyon.